[Biopharmaceutical studies of drug. IV. Studies on the improvement of dissolution properties and gastrointestinal absorption of 2-oxo-3-[4-(1-oxo-2-isoindolinyl)phenyl]butanamide (author's transl)].
D000818:Animals; D004285:Dogs; D007211:Indoles / Q000378:metabolism*; D007408:Intestinal Absorption; D054833:Isoindoles; D008297:Male; D010455:Peptides; D010592:Pharmaceutic Aids; D011208:Powders; D012995:Solubility
D007211:Indoles; D054833:Isoindoles; D010455:Peptides; D010592:Pharmaceutic Aids; D011208:Powders; C033477:2-oxo-3-(4-(1-oxo-2-isoindolinyl)phenyl)butanamide